Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEGIN Novel ImagiNG Biomarkers
NCT05517655Phase 4Active, not recruiting
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- May 2022
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hyperpolarized xenon gas in cystic fibrosis (CF), sponsored by Cincinnati Children's Hospital Medical Center. Started May 2022; status: active, not recruiting.
02
Drugs
hyperpolarized xenon gas
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT05517655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05517655.